Dynamics of the Upper and Lower Airway Respiratory Microbiomes Associated With Severe Infant Asthma
Recruiting
N/AInterventional Study
Asthma in ChildrenAsthma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
Up to 24 Months
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
100 (estimated)
Sponsor
University Hospital, Rouen · Other
Who this trial is looking for
This trial is looking for infants under 24 months old who have severe asthma. Participants will be followed by a doctor and may need specific tests and treatments for their asthma.
Are You a Good Fit for This Trial?
You may be able to join if
I am an infant less than 24 months old
I have severe asthma
I am being followed by a specialist doctor for my asthma
I need testing to understand my asthma and its severity
I have a parent who is informed about the research
My parent has signed consent for me to participate
You may not be able to join if
I was born prematurely before 32 weeks
I have significant congenital heart disease
I have a chronic respiratory disease other than asthma
I have taken antibiotics in the past 7 days
I refuse to have a bronchial fibroscopy
Summarized in plain language from this trial's official eligibility criteria.
The full criteria are further down this page — only the research team can
confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Nature of potential dysbiosis, interrelation of the different microbiomes of the respiratory tract, and potential role of the immune system in the pathogenesis of severe asthma in infants, and its evolution under treatment.
Exploring and understanding these data is to improve patient care and discover new therapeutic targets.
The aim is to open up prospects for therapeutic studies, such as the u…
Nature of potential dysbiosis, interrelation of the different microbiomes of the respiratory tract, and potential role of the immune system in the pathogenesis of severe asthma in infants, and its evolution under treatment.
Exploring and understanding these data is to improve patient care and discover new therapeutic targets.
The aim is to open up prospects for therapeutic studies, such as the use of azithromycin as an immunomodulator in infant asthma, the results of which are discordant.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Infants less than 24 months old
* Follow-up by a pneumo-pediatrician for severe asthma in infants
* Requiring etiological investigations and assessment of severity in day hospitalization, including bronchial fibroscopy (HAS 2009)
* Parent informed of the research and having si…
Inclusion Criteria:
* Infants less than 24 months old
* Follow-up by a pneumo-pediatrician for severe asthma in infants
* Requiring etiological investigations and assessment of severity in day hospitalization, including bronchial fibroscopy (HAS 2009)
* Parent informed of the research and having signed consent
Exclusion Criteria:
* Prematurity \<32 WA
* Congenital heart disease with significant left to right shunt
* Chronic respiratory disease other than infant asthma (cystic fibrosis, bronchiolitis obliterans)
* Antibiotic therapy in progress or administered the seven days preceding the date of inclusion (day hospitalization)
* Refusal of bronchial fibroscopy
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.